Cargando…
The safety of sotagliflozin in the therapy of diabetes mellitus type 1 and type 2: A meta-analysis of randomized trials
BACKGROUND: Diabetes mellitus (DM) is a global health problem, and it has become a shocking threat in the contemporary era. The objective of this study was to analyze the safety of sotagliflozin in patients with DM systematically and intuitively. METHODS: On November 15, 2021, literature retrieval w...
Autores principales: | Zhou, Feifei, Du, Nannan, Zhou, Lulin, Wang, Chenxi, Ren, He, Sun, Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548998/ https://www.ncbi.nlm.nih.gov/pubmed/36225203 http://dx.doi.org/10.3389/fendo.2022.968478 |
Ejemplares similares
-
Efficacy and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus: A systematic review and meta-analysis
por: Chen, Mao-Bing, et al.
Publicado: (2020) -
Effectiveness and safety of sotagliflozin adjuvant therapy for type 1 diabetes mellitus: A protocol for Systematic review and Meta-analysis
por: Chen, Mao-Bing, et al.
Publicado: (2019) -
A review of sotagliflozin for use in type 1 diabetes
por: Nuffer, Wesley, et al.
Publicado: (2019) -
Cardiovascular benefits and safety of sotagliflozin in type 2 diabetes mellitus patients with heart failure or cardiovascular risk factors: a bayesian network meta-analysis
por: Li, Jiyifan, et al.
Publicado: (2023) -
Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials
por: Musso, Giovanni, et al.
Publicado: (2019)